MedTrace Logo

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

NCT02558803 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1305

Last updated 2016-05-25

No results posted yet for this study

Summary

Randomized, 2-arm observational study. The 2 arms (randomized at the level of health care provider) will be: 1. usual practice; 2. automated reminders to recommend 2nd and 3rd doses of HPV vaccine for eligible male and female adolescents who have initiated vaccination.

Conditions

  • Human Papilloma Virus Infection Type 11
  • Human Papilloma Virus Infection Type 16
  • Human Papilloma Virus Infection Type 18
  • Human Papilloma Virus Infection Type 6
  • Cervical Cancer
  • Genital Warts
  • Oropharyngeal Cancer

Interventions

BEHAVIORAL

Simple Reminder

A simple reminder prompt in which CHICA will provide an immunization reminder to the physician that the child is eligible for the 2nd or 3rd dose of vaccine.

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Indiana University

    collaborator OTHER

  • Regenstrief Institute, Inc.

    lead OTHER

Principal Investigators

  • Gregory D Zimet, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02558803 on ClinicalTrials.gov